Allakos

ALLK

ALLK Allakos NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ALLK Chart
    See on advanced chart >

    About

    Allakos Inc. was incorporated in the state of Delaware in March 2012. The company is a clinical stage biotechnology company developing AK002, they wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases. AK002...
    • Highlight
      A clinical stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/19/2018
    • Established Date
      Invalid Date
    • Full-time Employees
      123
    • Address
      825 Industrial Road Suite 500 San Carlos California 94070
    • Tel
      1-650-5975002
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-23 10:22:23